Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure

Pharmacol Ther. 1984;24(2):165-77. doi: 10.1016/0163-7258(84)90033-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / analysis
  • Adult
  • Aged
  • Catecholamines / pharmacology*
  • Dihydroalprenolol / metabolism
  • Dobutamine / therapeutic use
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Heart Valve Diseases / drug therapy
  • Hemodynamics / drug effects
  • Humans
  • Imidazoles / pharmacology
  • Imidazoles / therapeutic use*
  • Impromidine
  • Male
  • Middle Aged
  • Myocardial Contraction / drug effects
  • Receptors, Adrenergic, beta / physiology
  • Receptors, Histamine / drug effects*
  • Receptors, Histamine H2 / drug effects*

Substances

  • Catecholamines
  • Imidazoles
  • Receptors, Adrenergic, beta
  • Receptors, Histamine
  • Receptors, Histamine H2
  • Dobutamine
  • Dihydroalprenolol
  • Impromidine
  • Adenylyl Cyclases